Share capital (Details Narrative) - USD ($) |
12 Months Ended | |||
|---|---|---|---|---|
Mar. 31, 2026 |
Mar. 31, 2025 |
Mar. 31, 2024 |
Apr. 11, 2024 |
|
| IfrsStatementLineItems [Line Items] | ||||
| Issue of ordinary shares | $ 0.0001 | $ 0.00001 | ||
| Issue of ordinary shares | 6,089,526 | 58,041,990 | ||
| Issuance of shares during the financial year | 31 | |||
| Proceeds from issuance of shares | $ 3,107,731 | $ 2,295,012 | ||
| Adjustment on acquisition of subsidiaries shares | 58,041,998 | |||
| Adjustment on acquisition of subsidiaries value | $ 580 | $ 13,531,607 | ||
| Issuance of shares pursuant to investment of combining entities value | $ 580 | |||
| Bottom of range [member] | ||||
| IfrsStatementLineItems [Line Items] | ||||
| Issue of ordinary shares | $ 10 | |||
| Alps Life Science Inc [member] | ||||
| IfrsStatementLineItems [Line Items] | ||||
| Converted into aggregate of new ordinary shares | 160,000,000 | |||
| Issue of ordinary shares | $ 0.0001 | $ 0.00001 | $ 0.00001 | |